drugset / Trial / NCT03043742
Stem Cell Heart Injections During Laser Revascularization Surgery for Treatment of Chronic Ischemic Heart Disease
NaSingle-groupOpen-labelTreatment
Summary
Assess the safety and effectiveness of stem cell application with regard to improvement in regional myocardial function in patients receiving Trans-Myocardial Laser Revascularization (TMR) and stem cells.
Timeline
- Start
- 2016-07-12
- Primary completion
- 2020-11-12
- Completion
- 2020-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bone Marrow Derived Autologous CD133+ Selected Cell Product | Cell therapy | 0.1 ml | Other |
| Subject | Bone Marrow Derived Autologous CD133+ Selected Cell Product | Cell therapy | 0.2 ml | Other |